Journal of Adolescent and Young Adult Oncology

Scope & Guideline

Connecting Research and Care for Young Cancer Warriors

Introduction

Immerse yourself in the scholarly insights of Journal of Adolescent and Young Adult Oncology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2156-5333
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2014 to 2024
AbbreviationJ ADOLESC YOUNG ADUL / J. Adolesc. Young Adult Oncol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The Journal of Adolescent and Young Adult Oncology aims to advance the understanding and treatment of cancer in adolescents and young adults (AYAs), focusing on the unique challenges faced by this population. It encompasses a broad range of interdisciplinary research, addressing medical, psychological, social, and economic aspects of cancer care for AYAs.
  1. Oncofertility and Reproductive Health:
    A significant focus on the implications of cancer treatment on fertility and reproductive health, including strategies for fertility preservation and psychosocial support for survivors.
  2. Psychosocial Impact and Support:
    Research examining the psychological, emotional, and social challenges faced by AYAs with cancer, including the development and evaluation of supportive care interventions.
  3. Health Care Transition and Coordination:
    Studies exploring the transition from pediatric to adult oncology care, emphasizing the need for tailored approaches to meet the unique needs of AYAs.
  4. Long-term Survivorship and Quality of Life:
    Investigations into the long-term effects of cancer treatment on survivors' quality of life, including physical health, mental well-being, and social reintegration.
  5. Clinical Outcomes and Treatment Innovations:
    Research involving clinical trials, treatment efficacy, and innovative therapies specifically tailored for the adolescent and young adult age group.
The Journal of Adolescent and Young Adult Oncology has identified several emerging themes in recent research that reflect the evolving landscape of oncology care for adolescents and young adults. These trends highlight the growing recognition of the unique challenges faced by this population and the need for targeted research and interventions.
  1. Integration of Telehealth in Oncology Care:
    The rise of telehealth services has become a significant trend, particularly in the context of providing accessible care and support to AYAs during and after the COVID-19 pandemic.
  2. Focus on Mental Health and Well-Being:
    A notable increase in research addressing the mental health challenges of AYAs with cancer, including anxiety, depression, and coping strategies, reflecting a broader understanding of holistic care.
  3. Financial Toxicity and Economic Burden:
    Emerging studies focusing on the financial implications of cancer treatment for AYAs, including the impact of financial stress on decision-making regarding treatment and survivorship.
  4. Peer Support Programs:
    Growing interest in peer support interventions that leverage the experiences of AYAs with cancer to provide relatable support and improve psychosocial outcomes.
  5. Exploration of Social Media as a Support Tool:
    Research into the role of social media in providing emotional support and information sharing among AYAs has gained traction, recognizing its importance in modern communication.

Declining or Waning

While the Journal of Adolescent and Young Adult Oncology continues to evolve, certain areas of research are witnessing a decline in focus. These waning themes may reflect changing priorities within the field, advancements in treatment approaches, or shifts in the interests of the research community.
  1. Traditional Chemotherapy Studies:
    There seems to be a reduced emphasis on studies solely focused on traditional chemotherapy regimens, as the field shifts towards exploring targeted therapies and personalized medicine for AYAs.
  2. Single-Symptom Management Research:
    Research concentrated on isolated symptoms, such as pain or nausea, is becoming less prominent in favor of holistic approaches that address multiple symptoms and overall quality of life.
  3. General Cancer Awareness Campaigns:
    The focus on broad cancer awareness initiatives is declining, with a shift towards more specific interventions that address the unique needs of AYAs, such as oncofertility and psychosocial support.

Similar Journals

Palliative & Supportive Care

Empowering Professionals in Palliative Excellence
Publisher: CAMBRIDGE UNIV PRESSISSN: 1478-9515Frequency: 6 issues/year

Palliative & Supportive Care, published by Cambridge University Press, is a pivotal journal dedicated to advancing research and practice in the fields of palliative care, supportive care, and the psychological aspects of terminal and chronic illness. With a robust ISSN of 1478-9515 and an E-ISSN of 1478-9523, this esteemed journal has established itself as a vital resource for professionals, researchers, and students who are committed to improving the quality of life for patients facing serious health challenges. Featuring peer-reviewed articles that span clinical psychology, medicine, nursing, and psychiatry, it holds a respectable impact factor, ranking Q2 in Clinical Psychology, Medicine, and Nursing as per the 2023 category quartiles. The journal is based in the United Kingdom and has been contributing to the field since its inception in 2003. Although it currently does not offer Open Access, its rigorously curated content underscores its relevance and importance in facilitating interdisciplinary dialogue and innovation in palliative and supportive care. For those seeking to stay at the forefront of research, Palliative & Supportive Care remains an indispensable platform for scholarly communication and discovery.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Shaping the Future of Cancer Care
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0277-3732Frequency: 12 issues/year

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, published by Lippincott Williams & Wilkins, is a pivotal journal in the fields of oncology and cancer research, focusing on the latest advancements in clinical trials and therapeutic strategies for cancer management. With an ISSN of 0277-3732 and an E-ISSN of 1537-453X, this journal serves as an essential resource for the dissemination of high-quality research findings, scholarly reviews, and innovative methodologies, aiming to advance clinical oncology from 1982 to 2024. It is categorized in Q3 for Cancer Research and Q2 for Oncology, reflecting its significant role in the scientific community. In addition to its rigorous peer-reviewed content, the journal provides a platform for researchers and clinicians to share valuable insights, laying the groundwork for future breakthroughs in cancer treatment. Although it currently does not offer open-access options, the journal remains accessible to a wide audience through academic institutions and libraries. The AMERICAN JOURNAL OF CLINICAL ONCOLOGY is crucial for anyone involved in oncology research, making it a must-read for professionals dedicated to improving cancer care.

PEDIATRIC HEMATOLOGY AND ONCOLOGY

Exploring breakthroughs in child hematology and oncology.
Publisher: TAYLOR & FRANCIS INCISSN: 0888-0018Frequency: 8 issues/year

Pediatric Hematology and Oncology, published by Taylor & Francis Inc, serves as a vital platform dedicated to the fields of hematology, oncology, and pediatrics, providing a comprehensive avenue for the dissemination of scholarly research and clinical advancements. With an ISSN of 0888-0018 and an E-ISSN of 1521-0669, this journal has successfully converged its expertise over the years from 1984 to 2024. Ranked in the Q3 category for Hematology and Oncology, alongside a Q2 ranking in Pediatrics, Perinatology, and Child Health (2023), it engages a diverse readership comprising researchers, healthcare professionals, and students eager to explore groundbreaking studies in child health and treatment methodologies. While it currently does not offer Open Access options, the journal is widely cited and recognized, particularly in its specialized fields, fostering a rich environment for dialogue and innovation in the management of pediatric hematological and oncological disorders. The journal is based in the United Kingdom at 530 Walnut Street, Ste 850, Philadelphia, PA 19106, making it an essential resource for those pursuing excellence in pediatric medical research.

Oncology in Clinical Practice

Connecting Theory and Practice in Oncology
Publisher: VIA MEDICAISSN: 2450-1654Frequency: 6 issues/year

Oncology in Clinical Practice is a vital resource in the field of oncology, published by VIA MEDICA in Poland. This peer-reviewed journal, with ISSN 2450-1654 and E-ISSN 2450-6478, aims to bridge the gap between clinical practice and cancer research, providing a platform for the dissemination of original research, reviews, and case studies. Since its inception in 2019, the journal has featured significant contributions to the understanding of cancer treatment and patient care, although it currently holds a Q4 ranking in Oncology with a Scopus rank of #313/404 and a 22nd percentile in the Medicine _ Oncology category. Though it is not an open-access journal, its content is invaluable for oncologists, researchers, and students, offering critical insights and advancements in clinical approaches to cancer management. With a commitment to enhancing patient outcomes through clinical evidence, Oncology in Clinical Practice serves as an essential reference for those dedicated to the fight against cancer.

Journal of Geriatric Oncology

Transforming geriatric oncology through innovative research.
Publisher: ELSEVIERISSN: 1879-4068Frequency: 6 issues/year

Journal of Geriatric Oncology, published by Elsevier, stands at the intersection of geriatric medicine and oncology, addressing the unique needs and challenges of cancer management in older adults. Since its inception in 2010, this esteemed journal has played a pivotal role in advancing research and clinical practices, aiming to improve the quality of life and treatment outcomes for elderly cancer patients. With its impressive categorization in the 2023 Q2 quartile for both Geriatrics and Gerontology and Oncology, the journal demonstrates a noteworthy impact within its fields, ranking #153 out of 404 in Medicine – Oncology and #45 out of 116 in Medicine – Geriatrics and Gerontology. Researchers and healthcare professionals are encouraged to access critical insights through its rigorous peer-reviewed articles, which offer cutting-edge research findings and clinical applications. As the field continues to evolve, the Journal of Geriatric Oncology remains a vital resource for those dedicated to fostering innovation in geriatric oncology.

Asia-Pacific Journal of Clinical Oncology

Shaping the future of oncology across the Asia-Pacific region.
Publisher: WILEYISSN: 1743-7555Frequency: 6 issues/year

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

JNCI-Journal of the National Cancer Institute

Driving excellence in cancer research since 1940.
Publisher: OXFORD UNIV PRESS INCISSN: 0027-8874Frequency: 12 issues/year

JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.

ONCOLOGY

Elevating the standards of oncology research and practice.
Publisher: KARGERISSN: 0030-2414Frequency: 12 issues/year

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

Asia-Pacific Journal of Oncology Nursing

Empowering Oncology Nursing Through Innovative Research
Publisher: ELSEVIER SCIENCE INCISSN: 2347-5625Frequency: 12 issues/year

Asia-Pacific Journal of Oncology Nursing, published by Elsevier Science Inc, serves as a vital resource for researchers, practitioners, and students involved in the fields of oncology and nursing within the Asia-Pacific region. Since its transition to Open Access in 2014, the journal has aimed to disseminate cutting-edge research and innovative practices that enhance the quality of nursing care in oncology. With its ISSN 2347-5625 and E-ISSN 2349-6673, this journal holds a Q3 rank in both Oncology and Nursing (Oncology Nursing) as of 2023, reflecting its commitment to addressing current challenges and advancements in the discipline. With a Scopus ranking of 252/404 in Medicine (Oncology) and 13/20 in Nursing (Oncology Nursing), it occupies a crucial position in the academic landscape, nurturing knowledge that directly impacts patient care in oncology settings. Located at STE 800, 230 Park Ave, New York, NY 10169, the journal encourages contributions that explore multifaceted aspects of oncology nursing from 2018 to 2024, making it an important platform for emerging voices and established experts alike.

SUPPORTIVE CARE IN CANCER

Fostering interdisciplinary collaboration in supportive care.
Publisher: SPRINGERISSN: 0941-4355Frequency: 12 issues/year

SUPPORTIVE CARE IN CANCER is a premier academic journal published by Springer, dedicated to advancing the understanding and management of supportive care for cancer patients. With a notable impact factor, the journal is recognized for its contribution to the fields of Oncology, Rehabilitation, and Nursing, achieving impressive rankings in Scopus, including Q1 for Oncology Nursing and Rehabilitation, and Q2 for general Oncology. Founded in 1993 and looking towards a promising future until 2024, it serves as a vital resource for researchers, professionals, and students engaged in these critical areas of healthcare. Although not an Open Access journal, its rigorous peer-reviewed articles provide valuable insights into innovative practices and evidence-based strategies that enhance patient quality of life during and after treatment. By bridging the gap between research and clinical practice, SUPPORTIVE CARE IN CANCER significantly influences patient outcomes and fosters interdisciplinary collaboration in patient support.